scholarly journals Ultrasound Assessment in Cardiogenic Shock Weaning: A Review of the State of the Art

2021 ◽  
Vol 10 (21) ◽  
pp. 5108
Author(s):  
Rebeca Muñoz-Rodríguez ◽  
Martín Jesús García-González ◽  
Pablo Jorge-Pérez ◽  
Marta M. Martín-Cabeza ◽  
Maria Manuela Izquierdo-Gómez ◽  
...  

Cardiogenic shock (CS) is associated with a high in-hospital mortality despite the achieved advances in diagnosis and management. Invasive mechanical ventilation and circulatory support constitute the highest step in cardiogenic shock therapy. Once established, taking the decision of weaning from such support is challenging. Intensive care unit (ICU) bedside echocardiography provides noninvasive, immediate, and low-cost monitoring of hemodynamic parameters such as cardiac output, filling pressure, structural disease, congestion status, and device functioning. Supplemented by an ultrasound of the lung and diaphragm, it is able to provide valuable information about signs suggesting a weaning failure. The aim of this article was to review the state of the art taking into account current evidence and knowledge on ICU bedside ultrasound for the evaluation of weaning from mechanical ventilation and circulatory support in cardiogenic shock.

2021 ◽  
Author(s):  
Xueqiao Li ◽  
Na Sun ◽  
Zhanfeng Li ◽  
Jinbo Chen ◽  
Qinjun Sun ◽  
...  

Perovskite solar cells (PSCs) have reached their highest efficiency with the state-of-the-art hole-transporting material (HTM) spiro-OMeTAD.


2011 ◽  
Vol 19 (4) ◽  
pp. 882-887 ◽  
Author(s):  
Juana Perpiñá-Galvañ ◽  
Miguel Richart-Martínez ◽  
Maria José Cabañero-Martínez ◽  
Inmaculada Martínez-Durá

The goal was to describe the content validity of a short version of the state subscale of Spielberger's "State-Trait Anxiety Inventory (STAI)", based on the original version adapted to Spanish, in Spanish patients receiving invasive mechanical ventilation (IMV). The sample consisted of 16 patients receiving IMV at the Alicante Hospital (Spain), who selected the items from the full Spanish version of the STAI-state that were most relevant to them. Items 1, 5, 9, 10, 12 and 20 from the original scale are the most relevant for the Spanish patients receiving IMV and 5 of these are included in the short version of the scale (83.3% agreement). The short scale has shown adequate content validity for Spanish patients receiving IMV.


2018 ◽  
Vol 3 (1) ◽  
pp. 821 ◽  
Author(s):  
Antony García ◽  
Yessica Sáez ◽  
José Muñoz ◽  
Ignacio Chang ◽  
Héctor Montes Franceschi

This article presents the state of the art on the use of radiofrequency communication for the detection of objects and vehicles in motion, through the interaction between transmitter and receiver devices using ISM (Industrial, Scientific and Medical) bands. By quantifying parameters such as the absence or presence of signals and their intensity, it is possible to approximate the distance between an emitting device and a receiver, localized in the vehicle and a fixed point, respectively . The study of the methodologies used in this article aims to develop a system oriented to guide people with visual disabilities in the public transportation system, taking advantage of the main characteristics of radiofrequency communication: low cost, easy implementation and full compatibility with electronic boards built on embedded systems.Keywords: radiofrequency, ISM bands, detection of vehicles in motion, support for visual disability people, ETA


2021 ◽  
Author(s):  
Zijun Wang ◽  
Siya Zhao ◽  
Yuyi Tang ◽  
Zhili Wang ◽  
Qianling Shi ◽  
...  

Abstract Introduction: The purpose of this systematic review is to evaluate the efficacy and safety of using potential drugs: remdesivir and glucocorticoid in treating children and adolescents with COVID-19 and intravenous immunoglobulin (IVIG) in treating MIS-C. Methods: We searched seven databases, three preprint platform, ClinicalTrials.gov, and Google from December 1, 2019, to August 5, 2021, to collect evidence of remdesivir, glucocorticoid, and IVIG which were used in children and adolescents with COVID-19 or MIS-C. Results: A total of nine cohort studies and one case series study were included in this systematic review. In terms of remdesivir, the meta-analysis of single-arm cohort studies have shown that, after the treatment, 54.7% (95%CI, 10.3% to 99.1%) experienced adverse events, 5.6% (95%CI, 1.2% to 10.1%) died, 27.0% (95%CI, 0% to 73.0%) needed extracorporeal membrane oxygenation or invasive mechanical ventilation. As for glucocorticoids, the results of the meta-analysis showed that the fixed-effect summary odds ratio for the association with mortality was 2.79 (95%CI, 0.13 to 60.87), and the mechanical ventilation rate was 3.12 (95%CI, 0.80 to 12.08) for glucocorticoids compared with the control group. In terms of IVIG, most of the included cohort studies showed that for MIS-C patients with more severe clinical symptoms, IVIG combined with methylprednisolone could achieve better clinical efficacy than IVIG alone.Conclusions: Overall, the current evidence in the included studies is insignificant and of low quality. It is recommended to conduct high-quality randomized controlled trials of remdesivir, glucocorticoids, and IVIG in children and adolescents with COVID-19 or MIS-C to provide substantial evidence for the development of guidelines.


2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
C Vandenbriele ◽  
T Balthazar ◽  
J Wilson ◽  
S Ledot ◽  
R Smith ◽  
...  

Abstract Background Acute mitral regurgitation (MR) is an emergency, often requiring urgent surgery. Severe acute MR presenting with hemodynamic collapse is usually caused by papillary muscle rupture or dysfunction after acute myocardial infarction (AMI) or chordal rupture, resulting in flail mitral leaflet(s). Preoperative stabilization is complex due to concomitant hemodynamic collapse and hypoxic respiratory failure. Finding the right balance between both preload and inotropic support is challenging. When patients are too sick for immediate surgical intervention, mechanical circulatory support can be considered because of its ability to both unload and reduce of cardiac work while increasing coronary perfusion and cardiac output. Nevertheless, even after initial stabilization, surgical risk remains high in critically ill acute severe MR patients and transcatheter treatments such as MitraClip are increasingly being explored. Methods Between August 2017 and September 2019, patients presenting with acute severe mitral regurgitation and considered too ill for immediate surgical intervention (EURO-II score >11.2% plus pulmonary oedema necessitating mechanical ventilation and/or hemodynamic instability), were selected for an Impella-assisted LV unloading technique as bridge to MitraClip-procedure. Five patients were selected for the combined left Impella/MitraClip-procedure in two tertiary cardiac ICUs. Results The mean age was 72 years. The cause of MR was ischemic in 20% and all patients presented in cardiogenic shock state, necessitating mechanical ventilation. The overall cardiac operative risk assessment (Euro-II) score predicted a 35% chance of in-hospital mortality. Cardiac output was severely impaired (mean LVOT VTI 8.2 cm). All patients were on inotropic support and supported by an Impella-CP pVAD (mean flow 2.5 Liter per minute; mean 6.3 days of support). In all cases, we managed to reduce the LVEDP below 15 mmHg using the combination of medical therapy (afterload reduction, inotropes), mechanical ventilation and pVAD-therapy. The MR was significantly reduced by a MitraClip-procedure in each Impella supported patient. The overall survival at discharge was 80%. One patient with late referral and multiple organ failure at presentation deceased due to refractory cardiogenic shock. Overall, severe MR was reduced to grade 1+ and all four patients survived 6 months after discharge with only one readmission for decompensated heart failure. Conclusions A combined strategy of Impella and MitraClip appears to be a novel, feasible alternative for patients presenting with acute, severe MR unable to proceed to a corrective surgical procedure at presentation due to severe left ventricular forward flow failure. In these cases, the early initiation of pVAD-support may reduce the risk of development of irreversible end- organ damage and dysfunction. Exploration in a larger, randomised population is warranted to investigate this strategy further. Funding Acknowledgement Type of funding source: None


2019 ◽  
Vol 40 (32) ◽  
pp. 2671-2683 ◽  
Author(s):  
Holger Thiele ◽  
E Magnus Ohman ◽  
Suzanne de Waha-Thiele ◽  
Uwe Zeymer ◽  
Steffen Desch

Abstract Cardiogenic shock (CS) remains the most common cause of death in patients admitted with acute myocardial infarction (AMI) and mortality remained nearly unchanged in the range of 40–50% during the last two decades. Early revascularization, vasopressors and inotropes, fluids, mechanical circulatory support, and general intensive care measures are widely used for CS management. However, there is only limited evidence for any of the above treatment strategies except for revascularization and the relative ineffectiveness of intra-aortic balloon pumping. This updated review will outline the management of CS complicating AMI with major focus on state-of-the art treatment.


2017 ◽  
Vol 230 ◽  
pp. 191-197 ◽  
Author(s):  
Mari Hongisto ◽  
Johan Lassus ◽  
Tuukka Tarvasmaki ◽  
Alessandro Sionis ◽  
Heli Tolppanen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document